Brad Gray has been named CEO and president at NanoString Technologies, and Nalini Murdter has been appointed chief business officer.
Gray joins NanoString from Genzyme Genetics, the diagnostic services division of Genzyme, where he was most recently vice president of product and business development. Gray previously was a management consultant at McKinsey & Company. He holds a BA in economics and management from Oxford University, and an SB in chemical engineering from the Massachusetts Institute of Technology.
Murdter joins NanoString from Agilent Technologies, where she held several roles, including global product marketing manager in the firm's Life Sciences and Chemical Analysis division. Prior to Agilent, Murdter was director of product and business development at Adeza Biomedical. She holds a PhD in biochemistry from the University of Maryland and an MBA from the University of California Berkeley.
Caitlin Cameron has joined Presage Biosciences as CEO. She previously was CEO of CellNetix, a pathology and laboratory company. Cameron also spent 13 years at AT&T.
Thane Kreiner, Presage's former CEO, will continue to serve as a strategic advisor to Presage, the company said.
Fred Walder has been appointed chief business officer at Fluidigm. Walder was most recently senior vice president of customer and commercial excellence at Thermo Fisher Scientific. He also held positions at Nicolet Instrument Corp. and Sandia National Laboratories.
RainDance Technologies has tapped Alan Sherr to serve as vice president and chief intellectual property counsel. Sherr previously was VP and chief intellectual property counsel at Helicos BioSciences and was senior IP counsel and VP of licensing at Affymetrix.
Shane Lyons will be AB Sciex's VP of Americas sales, support, and customer service operations. Lyons recently was global VP of sales and marketing for GenVault, and before that he worked for Applied Biosystems for 12 years. He also previously worked at Abbott Laboratories.